Treatment of Vasospasm Secondary to Subarachnoid Hemorrhage Using Intra-Arterial Nimodipine in Low Dosage
Alexandra Bandeira, Carla Josefine Barbosa de Lima Ribeiro, João Reis
Abstract
Alexandra Bandeira, Carla Josefine Barbosa de Lima Ribeiro, João Reis
Abstract
SUMMARY: There are currently no consensus criteria to define the dosage of intra-arterial Nimodipine to be used to obtain permanent remission of vasospasm secondary to subarachnoid haemorrhage. The purpose of this paper is to establish a mathematical relation between the number of vessels affected by this kind of vasospasm and the Nimodipine dose that must be used for intra- arterial angioplasty to obtain permanent remission of the vasospasm.
OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
SUMMARY: There are currently no consensus criteria to define the dosage of intra-arterial Nimodipine to be used to obtain permanent remission of vasospasm secondary to subarachnoid haemorrhage. The purpose of this paper is to establish a mathematical relation between the number of vessels affected by this kind of vasospasm and the Nimodipine dose that must be used for intra- arterial angioplasty to obtain permanent remission of the vasospasm.
Key concepts: Nimodipine, Medicine, Vasospasm, Subarachnoid hemorrhage, Anesthesia, Angioplasty, Cerebral vasospasm, Cardiology